Myelodysplastic Syndrome With Isolated Del(5Q)

11 clinical trials · Condition

Sort:Newest first Oldest first

◉ Watch Myelodysplastic Syndrome With Isolated Del(5Q)

Record	Firm	Date
Haploinsufficiency of the RBM22 and SLU7 Genes in Del(5q) Myelodysplastic Syndromes (NCT04701229)	University Hospital, Brest	2020-09-30
WEE1 Inhibitor AZD1775 With or Without Cytarabine in Treating Patients With Advanced Acute Myeloid Leukemia or Myelodysplastic Syndrome (NCT02666950)	Mayo Clinic	2017-05-05
Sirolimus and Azacitidine in Treating Patients With High Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia That is Recurrent or Not Eligible for Intensive Chemotherapy (NCT01869114)	Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University	2013-07-08
Vorinostat, Tacrolimus, and Methotrexate in Preventing GVHD After Stem Cell Transplant in Patients With Hematological Malignancies (NCT01789255)	National Cancer Institute (NCI)	2013-06-01
Deferasirox in Treating Iron Overload Caused By Blood Transfusions in Patients With Hematologic Malignancies (NCT01273766)	Wake Forest University Health Sciences	2011-01-01
Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy (NCT00890747)	National Cancer Institute (NCI)	2009-08-01
Clofarabine and Cytarabine in Treating Older Patients With AML or High-Risk MDS (NCT00839982)	Fred Hutchinson Cancer Center	2008-11-01
Cyclophosphamide and Busulfan Followed by Donor Stem Cell Transplant in Treating Patients With Myelofibrosis, Acute Myeloid Leukemia, or Myelodysplastic Syndrome (NCT00445744)	Fred Hutchinson Cancer Center	2006-12-01
Low-Dose or High-Dose Conditioning Followed by Peripheral Blood Stem Cell Transplant in Treating Patients With Myelodysplastic Syndrome or Acute Myelogenous Leukemia (NCT00322101)	Fred Hutchinson Cancer Center	2006-01-01

Track Myelodysplastic Syndrome With Isolated Del(5Q) automatically

Every clearance here is in the API, with alerts when new ones post.